Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US9662390B2 · kind B2 · utility
0Cited by
128References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 7, 2006 |
| Grant date | May 30, 2017 |
| Priority date | — |
| Expiry date | Mar 7, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides methods of attenuating, e.g., inhibiting or reducing, cellular proliferation and migration, particularly endothelial cell proliferation and migration, including that associated with angiogenesis, using opioid antagonists, including, but not limited to, those that are peripherally restricted antagonists.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.